SAFZOX™ Injection combines the antibacterial activity of Cefpirome, a fourth-generation cephalosporin, with Sulbactam, a β-lactamase inhibitor. This combination is designed to provide broad antibacterial coverage while helping overcome resistance caused by β-lactamase-producing bacteria.

Brand Composition

Each 1.5 g vial contains:

• Cefpirome – 1 g
• Sulbactam – 500 mg
• Total Strength – 1.5 g

Key Features

• Combines a fourth-generation cephalosporin with a β-lactamase inhibitor.
• Provides broad-spectrum antibacterial activity.
• Sulbactam helps inhibit β-lactamase enzymes produced by certain bacteria.
• Designed to help address bacterial resistance associated with β-lactamase production.
• Conveniently provided as a 1.5 g vial containing Cefpirome 1 g and Sulbactam 500 mg.

Composition at a Glance

⚠️ Note-   For use under the supervision of a qualified healthcare professional. The appropriate dose, route of administration, duration of treatment and suitability should be determined by the treating healthcare professional based on the patient's clinical condition and other relevant factors. Antibiotics should be used only when prescribed and as directed.